Showing 4,201 - 4,220 results of 28,797 for search '(( 5 ((ng decrease) OR (teer decrease)) ) OR ( 50 ((a decrease) OR (mean decrease)) ))', query time: 0.94s Refine Results
  1. 4201

    The decline of an urban Hooded Vulture <i>Necrosyrtes monachus</i> population in Dakar, Senegal, over 50 years<sup>§</sup> by Wim C Mullié (4260322)

    Published 2017
    “…As the Hooded Vulture is still common in the Lower Casamance, Senegal, in the Western Region of The Gambia and in Guinea-Bissau, without clear signs of a recent decrease, a survey of its current status in Dakar was undertaken and compared with historical data over the past 50 years. …”
  2. 4202

    Expression of TPI, VIM and MAT2A in native cells. by Christina Herre (12475755)

    Published 2023
    “…</b> Western blot analysis of TPI, VIM and MAT2A in N<sub>1</sub> and N<sub>2</sub> at day 5, 15, 25 and 50 using ACT as internal control.…”
  3. 4203

    Anticancer Activity Expressed by a Library of 2,9-Diazaperopyrenium Dications by Karel J. Hartlieb (1367880)

    Published 2016
    “…Herein, we discuss an alternative, water-soluble class of polyaromatic compounds, the 2,9-diazaperopyrenium dications, and report <i>in vitro</i> cell studies for a library of these dications. These investigations reveal that a number of 2,9-diazaperopyrenium dications show similar activities as doxorubicin toward a variety of cancer cell lines. …”
  4. 4204

    Anticancer Activity Expressed by a Library of 2,9-Diazaperopyrenium Dications by Karel J. Hartlieb (1367880)

    Published 2016
    “…Herein, we discuss an alternative, water-soluble class of polyaromatic compounds, the 2,9-diazaperopyrenium dications, and report <i>in vitro</i> cell studies for a library of these dications. These investigations reveal that a number of 2,9-diazaperopyrenium dications show similar activities as doxorubicin toward a variety of cancer cell lines. …”
  5. 4205

    Anticancer Activity Expressed by a Library of 2,9-Diazaperopyrenium Dications by Karel J. Hartlieb (1367880)

    Published 2016
    “…Herein, we discuss an alternative, water-soluble class of polyaromatic compounds, the 2,9-diazaperopyrenium dications, and report <i>in vitro</i> cell studies for a library of these dications. These investigations reveal that a number of 2,9-diazaperopyrenium dications show similar activities as doxorubicin toward a variety of cancer cell lines. …”
  6. 4206

    Anticancer Activity Expressed by a Library of 2,9-Diazaperopyrenium Dications by Karel J. Hartlieb (1367880)

    Published 2016
    “…Herein, we discuss an alternative, water-soluble class of polyaromatic compounds, the 2,9-diazaperopyrenium dications, and report <i>in vitro</i> cell studies for a library of these dications. These investigations reveal that a number of 2,9-diazaperopyrenium dications show similar activities as doxorubicin toward a variety of cancer cell lines. …”
  7. 4207

    Anticancer Activity Expressed by a Library of 2,9-Diazaperopyrenium Dications by Karel J. Hartlieb (1367880)

    Published 2016
    “…Herein, we discuss an alternative, water-soluble class of polyaromatic compounds, the 2,9-diazaperopyrenium dications, and report <i>in vitro</i> cell studies for a library of these dications. These investigations reveal that a number of 2,9-diazaperopyrenium dications show similar activities as doxorubicin toward a variety of cancer cell lines. …”
  8. 4208

    Synthesis and Activity of a Novel Autotaxin Inhibitor–Icodextrin Conjugate by Natalie Fisher (1860283)

    Published 2018
    “…The conjugate inhibits autotaxin activity (IC<sub>50</sub> = 0.86 ± 0.13 μg mL<sup>–1</sup>) and reduces cell migration. …”
  9. 4209
  10. 4210
  11. 4211
  12. 4212
  13. 4213
  14. 4214
  15. 4215

    Effect of V3, MPER and IDR peptides on ID50 neutralization titers of the cross-neutralizing plasma in depletion and competition experiments. by Raiees Andrabi (138046)

    Published 2012
    “…</p>b<p><b>ID<sub>50</sub> fold decrease</b>; Plasma ID50 fold decrease for depletion assay was calculated as, ID50 with mock depleted plasma/ID50 with V3, MPER and IDR depleted plasma, and for competition assay as ID50 with untreated plasma/ID50 with V3, MPER and IDR treated plasma. …”
  16. 4216
  17. 4217
  18. 4218
  19. 4219
  20. 4220